Fig. 3From: Comprehensive preclinical studies on the bioactivity of Orbignya phalerata Mart. (Babassu) and its derived products: a systematic reviewAssessed outcomes from in vivo (A) and in vitro (B). Some publications have more than one outcomeBack to article page